SciTransfer
Organization

THE SALK INSTITUTE FOR BIOLOGICAL STUDIES

US biological research centre hosting EU MSCA fellows in primate optogenetics, visual neuroscience, and metabolic disorder molecular biology.

Research institutehealthUSNo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
Unique partners
2
What they do

Their core work

The Salk Institute is an independent biological research centre (REC) based in La Jolla, California, conducting experimental work across neuroscience, molecular biology, and metabolic disease. In the H2020 programme, they appeared exclusively as a third-party host institution for Marie Skłodowska-Curie Global Fellows — European researchers who travelled to Salk to conduct experimental work before returning to EU institutions. Their two H2020-linked projects span two distinct domains: systems neuroscience (using optogenetic tools to causally study visual feedback in primate cortex) and molecular biology (investigating small open reading frames as drivers of dietary-excess metabolic disorders). The institute functions as a broad-spectrum research host rather than a single-track EU collaborator.

Core expertise

What they specialise in

Optogenetics and visual neuroscienceprimary
1 project

OptoFeedback (2017–2020) used optogenetic manipulation in primate visual cortex to causally test the role of feedback circuits in border-ownership and figure-ground perception.

Primate systems neuroscienceprimary
1 project

OptoFeedback explicitly studied feedback in primate visual cortex, indicating access to primate research infrastructure and expertise in non-human primate experimental models.

Small open reading frame (smORF) biology and metabolic diseasesecondary
1 project

LIPMETIN-sURFing (2018–2021) investigated smORFs as novel modulators of disorders of dietary excess, linking non-canonical genomic elements to metabolic pathology.

Evolution & trajectory

How they've shifted over time

Early focus
Optogenetics and visual feedback circuits
Recent focus
smORF biology and metabolic disorders

Both H2020-linked projects fall within a narrow 2017–2018 window, making meaningful temporal evolution within EU project data impossible to establish. The earlier project (OptoFeedback) was firmly in systems neuroscience and optogenetics, while the subsequent project (LIPMETIN-sURFing) moved into a completely different domain — smORF genomics and metabolic disease — with no keyword overlap. This suggests the Salk hosts diverse, independently conceived research agendas through MSCA fellowships rather than building a cumulative thematic thread in its EU-facing work.

The complete disciplinary shift between the two recorded projects — neuroscience to molecular metabolism — signals that the Salk's EU-facing profile is shaped by which individual European researchers choose it as a host, not by an institute-level EU research strategy; future partners should expect broad disciplinary range rather than thematic continuity.

Collaboration profile

How they like to work

Role: third_party_expertReach: Global2 countries collaborated

As a US institution, the Salk Institute cannot act as an EU project coordinator and appears exclusively as a third-party host in both recorded H2020 projects. MSCA Global Fellowship involvement is by definition bilateral — one European fellow hosted for a defined period — rather than consortium-based, so their EU collaboration footprint is deliberately narrow. Partners should expect a depth-first model: intensive collaboration with individual researchers, not broad multi-partner network activity.

Within H2020 data, the Salk shows only 2 unique consortium partners across 2 countries — a direct consequence of the one-fellow-per-project MSCA Global Fellowship structure rather than a reflection of limited international connections. Their recorded EU partner count understates their actual international reach significantly.

Why partner with them

What sets them apart

Within H2020 data, the Salk appears as a non-EU destination that European researchers actively chose for prestigious individual fellowships — a signal of specialized research infrastructure, particularly in optogenetics and primate neuroscience, that is difficult to replicate within the EU. Unlike standard consortium partners, they bring no co-funding and cannot hold coordinator roles, but they provide access to experimental capabilities and scientific environments unavailable inside Europe. For consortium builders and MSCA applicants, they are best treated as a high-value external scientific node rather than a recurring consortium partner.

Notable projects

Highlights from their portfolio

  • OptoFeedback
    Combined optogenetic circuit manipulation with primate visual cortex recording to causally address a fundamental open question in perception — the function of top-down feedback in figure-ground segregation — a technically demanding approach that required both the specialized tools and the primate facilities the Salk provides.
  • LIPMETIN-sURFing
    Targeted smORFs — a largely unexplored layer of the genome — as potential therapeutic entry points for metabolic disorders of dietary excess, placing the Salk at the intersection of non-canonical genomics and translational metabolic medicine.
Cross-sector capabilities
Neurotechnology and optogenetic tooling applicable to brain-machine interface researchGenomics and non-coding element biology (smORF, translational regulation)Metabolic and obesity-related disease mechanisms
Analysis note: Only 2 projects, both as third-party MSCA host with no EC funding data (expected for a non-EU institution). The two projects cover unrelated research domains with no keyword overlap, making it impossible to establish a coherent thematic EU-facing profile from the data alone. The analysis_note acknowledges that the institute's classification as a US-based REC and its role as an MSCA host destination are derivable from the project data; broader characterizations of research breadth are inferred from the divergent project topics, not from external sources.